Health plans are being asked to solve for total cost of care across a growing set of overlapping conditions — obesity, diabetes, hypertension, cholesterol, and multi-condition members at the intersection of all of them. GLP-1 utilization has intensified the pressure, surfacing sustainability questions that no single-condition vendor is positioned to answer on its own. This webinar reframes the payer conversation from vendor evaluation to partner strategy, focusing on how a multi-condition cardiometabolic care platform can plug into a plan’s own total-cost-of-care approach across multiple lines of business.
This conversation will explore what “partner, not vendor” looks like in practice for fully-insured, ASO, Medicare, Medicaid, and federal employee cohorts, and how plans can evaluate multi-condition care solutions on the terms that actually matter: cost defensibility, clinical efficacy their teams can stand behind, and a partnership model built on care across conditions, rather than single-condition vendors.